GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lasa Supergenerics Ltd (NSE:LASA) » Definitions » Debt-to-Equity

Lasa Supergenerics (NSE:LASA) Debt-to-Equity : 0.23 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lasa Supergenerics Debt-to-Equity?

Lasa Supergenerics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹221 Mil. Lasa Supergenerics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0 Mil. Lasa Supergenerics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹967 Mil. Lasa Supergenerics's debt to equity for the quarter that ended in Mar. 2024 was 0.23.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lasa Supergenerics's Debt-to-Equity or its related term are showing as below:

NSE:LASA' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.12   Med: 0.29   Max: 1.59
Current: 0.23

During the past 9 years, the highest Debt-to-Equity Ratio of Lasa Supergenerics was 1.59. The lowest was 0.12. And the median was 0.29.

NSE:LASA's Debt-to-Equity is ranked better than
57.02% of 847 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs NSE:LASA: 0.23

Lasa Supergenerics Debt-to-Equity Historical Data

The historical data trend for Lasa Supergenerics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lasa Supergenerics Debt-to-Equity Chart

Lasa Supergenerics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only 0.34 0.12 0.13 0.18 0.23

Lasa Supergenerics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 N/A 0.01 N/A 0.23

Competitive Comparison of Lasa Supergenerics's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lasa Supergenerics's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lasa Supergenerics's Debt-to-Equity falls into.



Lasa Supergenerics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lasa Supergenerics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Lasa Supergenerics's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lasa Supergenerics  (NSE:LASA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Lasa Supergenerics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lasa Supergenerics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lasa Supergenerics (NSE:LASA) Business Description

Traded in Other Exchanges
Address
Andheri Kurla Road, Office No. 506 AND 507, 5th Floor Midas, Sahar Plaza, Andheri East, Mumbai, MH, IND, 400059
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, Pharmaceuticals, drugs, and others. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products.

Lasa Supergenerics (NSE:LASA) Headlines

No Headlines